Inactief instrument

Koers Abaco Capital PLC

Aandelen

Duur

Periode

Stijl

Oxford Pharmascience : Completion of Demerger, Board Changes & Change of Company Name to Abaco Capital plc	21-12-17
Oxford Pharmascience : Confirmation of Capital Reductions	19-12-17
Oxford Pharmascience : Subdivision of Capital	04-12-17
Oxford Pharmascience : FDA Pre-IND Advice on OXPzero™ Ibuprofen OTC Opportunity	29-11-17
Oxford Pharmascience : Result of General Meeting	27-11-17

Sector

	Vaira. 1 jan.	Kapi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+196,57%	7,18 mld.
CHURCHILL CAPITAL CORP VII	+2,10%	982 mln.
APPLE ISPORTS GROUP, INC.	+41,91%	872 mln.
PERELLA WEINBERG PARTNERS	+24,28%	806 mln.
ARES ACQUISITION CORPORATION II	+1,82%	664 mln.
E7 GROUP	+6,82%	642 mln.
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600 mln.
ADMIRAL ACQUISITION LIMITED	+3,61%	503 mln.
CAPITOL INVESTMENT CORP. VII	-.--%	500 mln.